Funktionsmenü_neu

Hauptnavigation

Current Investor News

Thursday September 04, 2008

Setting the course after a very successful first half of 2008:
Bayer CropScience plans investment of EUR 3.4 billion in research and development through 2012
Expansion of R&D program will strengthen basis for future growth / Achievement of target EBITDA margin of around 25 percent already expected in 2008 / Sales target of EUR 2 billion with new active ingredients now envisaged for 2009 / Launch of 10 new crop protection compounds with a peak sales potential of more than EUR 1 billion planned through 2012

Tuesday September 02, 2008

Bayer Submits Recombinant Human Thrombin for European Approval
Recothrom® would be the first recombinant human thrombin for use as a topical aid to surgical hemostasis in Europe

Highlights

 

Bayer CropScience Annual Press Conference on September 4, 2008

On-Demand Recording: Q2 2008 Investor Conference Call   PDF / 248 KB collectQ2_2008_ConferenceCall_2008-07-30_Redecharts.pdf Redecharts Q2 2008 Investor Conference Call

Financial Report as of June 30, 2008   PDF / 1.04 MB collectQB_2008_2_e.pdf Financial Report as of June 30, 2008

Acquisition of Schering AG - Full details

Current Events
Wednesday, October 29, 2008
Q3 2008 Investor Conference CallRemind
Tuesday, September 30, 2008
Meet Management in September, LeverkusenRemind
Latest Reports and Handout